patent/WO-0226728-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fe6555f9b0c8d86dc3ec514372767f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_882cf4753e3fae07aeacb2bdea04a218
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate	2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294032aad1539e0942047c7a894c32b5
publicationDate	2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0226728-A3
titleOfInvention	Antiviral methods and compounds
abstract	The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
priorityDate	2000-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4315862-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30219 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511441 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422956884 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21668219

Total number of triples: 19.